Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

NCT: NCT00912041 · RECRUITING

NCT IDNCT00912041
StatusRECRUITING
Start Date2009-05
Completion2038-12
SponsorLeigh R. Hochberg, MD, PhD. (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

Frequently Asked Questions

What is BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia?

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia is a clinical trial registered under NCT00912041. Current status: RECRUITING.

What is the status of NCT00912041?

The current status of NCT00912041 (BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia) is: RECRUITING.

When did BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia start?

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia started on 2009-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑